Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Vulval cancer
ADR ID BADD_A07830
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.08      Vulval neoplasms malignant
16.12.08.001      Vulval cancer
21      Reproductive system and breast disorders
21.08      Vulvovaginal disorders (excl infections and inflammations)
21.08.03      Vulvovaginal cysts and neoplasms
21.08.03.005      Vulval cancer
Description Tumors or cancer of the VULVA. [MeSH]
MedDRA Code 10047741
MeSH ID D014846
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Malignant neoplasm of clitoris | Malignant neoplasm of labia majora | Malignant neoplasm of labia minora | Malignant neoplasm of vulva, unspecified | Pott's carcinoma | Vulval cancer | Vulval cancer NOS | Vulvar cancer | Vulvar carcinoma | Vulvar Neoplasms | Neoplasm, Vulvar | Vulvar Neoplasm | Neoplasms, Vulvar | Vulva Neoplasms | Neoplasm, Vulva | Neoplasms, Vulva | Vulva Neoplasm | Cancer of Vulva | Vulva Cancers | Cancer of the Vulva | Vulva Cancer | Cancer, Vulva | Cancers, Vulva | Vulvar Cancer | Cancer, Vulvar | Cancers, Vulvar | Vulvar Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01831Prednisolone0.000035%
BADD_D01909Ramipril0.000326%
BADD_D01913Ranitidine0.000063%
BADD_D02236Tofacitinib0.000362%
BADD_D02331Valsartan0.000053%
BADD_D02464Fingolimod0.000482%
The 1th Page    1    Total 1 Pages